Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711 ; volume:16 ; number:1 ; day:9 ; month:5 ; year:2018 ; pages:1-14 ; date:12.2018
Journal of translational medicine ; 16, Heft 1 (9.5.2018), 1-14, 12.2018
- Urheber
-
Lindström, Erik
- Beteiligte Personen und Organisationen
-
Rizoska, Biljana
Henderson, Ian
Terelius, Ylva
Jerling, Markus
Edenius, Charlotte
Grabowska, Urszula
SpringerLink (Online service)
- DOI
-
10.1186/s12967-018-1497-4
- URN
-
urn:nbn:de:101:1-2018072917314656592213
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lindström, Erik
- Rizoska, Biljana
- Henderson, Ian
- Terelius, Ylva
- Jerling, Markus
- Edenius, Charlotte
- Grabowska, Urszula
- SpringerLink (Online service)
Ähnliche Objekte (12)
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections
Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats
The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis
Virtual Control Groups in Nonclinical Studies
Complementaktivierung durch Cathepsin D
Cathepsin X deficiency alters the processing and localisation of cathepsin L and impairs cleavage of a nuclear cathepsin L substrate
Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist
Expression and significance of cathepsin C and cathepsin D during pregnancy and Preeclampsia
Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors
Voice-selective prediction alterations in nonclinical voice hearers
Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections
Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats
The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis
Virtual Control Groups in Nonclinical Studies
Complementaktivierung durch Cathepsin D
Cathepsin X deficiency alters the processing and localisation of cathepsin L and impairs cleavage of a nuclear cathepsin L substrate
Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist
Expression and significance of cathepsin C and cathepsin D during pregnancy and Preeclampsia
Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors
Voice-selective prediction alterations in nonclinical voice hearers
Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections
Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats
The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis
Virtual Control Groups in Nonclinical Studies
Complementaktivierung durch Cathepsin D
Cathepsin X deficiency alters the processing and localisation of cathepsin L and impairs cleavage of a nuclear cathepsin L substrate
Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist
Expression and significance of cathepsin C and cathepsin D during pregnancy and Preeclampsia
Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors
Voice-selective prediction alterations in nonclinical voice hearers